Molecular mechanisms underlying chemical liver injury
暂无分享,去创建一个
[1] G. Poli,et al. The role of lipid peroxidation in liver damage. , 1987, Chemistry and physics of lipids.
[2] N. Kaplowitz,et al. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[3] C. Cross,et al. Oxygen-derived species: their relation to human disease and environmental stress. , 1994, Environmental health perspectives.
[4] J. Farber,et al. Mechanisms of cell injury by activated oxygen species. , 1994, Environmental health perspectives.
[5] Magnus Ingelman-Sundberg,et al. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects , 2010, Human Genomics.
[6] D A Smith,et al. Role of reactive metabolites in drug-induced hepatotoxicity. , 2010, Handbook of experimental pharmacology.
[7] H. Zimmerman,et al. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .
[8] Mark Feldman,et al. Sleisenger and Fordtran's gastrointestinal and liver disease , 2012 .
[9] S. Hsia,et al. Macromolecular adducts: biomarkers for toxicity and carcinogenesis. , 1994, Annual review of pharmacology and toxicology.
[10] Jianghong Fan,et al. Interplay of transporters and enzymes in drug and metabolite processing. , 2009, Molecular pharmaceutics.
[11] P. Ghezzi,et al. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. , 2005, Antioxidants & redox signaling.
[12] J. Hiatt,et al. Acetaminophen hepatotoxicity and acute liver failure. , 2009, Journal of clinical gastroenterology.
[13] R. G. Allen,et al. Oxidative stress and gene regulation. , 2000, Free radical biology & medicine.
[14] R. Zangar,et al. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. , 2004, Toxicology and applied pharmacology.
[15] Shufeng Zhou. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. , 2008, Current drug metabolism.
[16] Neil Kaplowitz,et al. Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.
[17] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[18] M. Daly,et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin , 2009, Nature Genetics.
[19] A. Kong,et al. Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. , 2009, Biopharmaceutics & drug disposition.
[20] R. Gebhardt. Metabolic zonation of the liver: regulation and implications for liver function. , 1992, Pharmacology & therapeutics.
[21] W. Pichler,et al. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. , 2004, The Journal of allergy and clinical immunology.
[22] Hugo O Villar,et al. Ring systems in mutagenicity databases. , 2005, Journal of medicinal chemistry.
[23] M. Morgan,et al. Managing alcohol dependence and alcohol-related liver disease: a problem for the hepatologist, psychiatrist or economist? , 2011, Clinical medicine.
[24] J. Chipman,et al. Chloroform, carbon tetrachloride and glutathione depletion induce secondary genotoxicity in liver cells via oxidative stress. , 2003, Toxicology.
[25] William Stafford Noble,et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.
[26] M. Dizdaroglu,et al. Free radical-induced damage to DNA: mechanisms and measurement. , 2002, Free radical biology & medicine.
[27] L. Klassen,et al. Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption. , 2008, Methods in molecular biology.
[28] Life Technologies,et al. A map of human genome variation from population-scale sequencing , 2011 .
[29] G. Gores,et al. Hepatocyte death: a clear and present danger. , 2010, Physiological reviews.
[30] G. Perdew,et al. Role of the aryl hydrocarbon receptor in drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.
[31] Benveniste,et al. Cytochrome P450 , 1993, Handbook of Experimental Pharmacology.
[32] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[33] J. Lemasters. V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[34] P. Meier,et al. Hepatobiliary transporters and drug‐induced cholestasis , 2006, Hepatology.
[35] Jianwen Fang,et al. The reactive metabolite target protein database (TPDB) – a web-accessible resource , 2007, BMC Bioinformatics.
[36] Bernard Testa,et al. The Biochemistry of Drug Metabolism — An Introduction. Part 2. Redox Reactions and Their Enzymes , 2007 .
[37] T. Mak,et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.
[38] R. Mason,et al. Free radicals in toxicology. , 1993, Toxicology and applied pharmacology.
[39] R. Brůha,et al. Alcoholic liver disease. , 2012, World journal of hepatology.
[40] T. Sit,et al. Unique Transcription Start Sites and Distinct Promoter Regions Differentiate the Pregnane X Receptor (PXR) Isoforms PXR 1 and PXR 2 , 2008, Drug Metabolism and Disposition.
[41] T. Zima,et al. Oxidative stress and signal transduction pathways in alcoholic liver disease. , 2005, Alcoholism, clinical and experimental research.
[42] L. Nagy. Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease , 2003, Experimental biology and medicine.
[43] R. Barouki. Linking long-term toxicity of xeno-chemicals with short-term biological adaptation. , 2010, Biochimie.
[44] K. Jungermann,et al. Zonation of parenchymal and nonparenchymal metabolism in liver. , 1996, Annual review of nutrition.
[45] A. Kalgutkar. Handling reactive metabolite positives in drug discovery: What has retrospective structure-toxicity analyses taught us? , 2011, Chemico-biological interactions.
[46] Dean P. Jones,et al. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. , 2006, Annual review of pharmacology and toxicology.
[47] Tak Yee Aw,et al. Glutathione and apoptosis , 2008, Free radical research.
[48] G. Gores,et al. Apoptosis as a mechanism for liver disease progression. , 2010, Seminars in liver disease.
[49] J. Galligan,et al. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. , 2011, Chemico-biological interactions.
[50] Gary M Williams,et al. Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity , 2002, Toxicologic pathology.
[51] Dean P. Jones,et al. Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. , 2010, Molecular interventions.
[52] C. Martinez-Jimenez,et al. Transcriptional regulation and expression of CYP3A4 in hepatocytes. , 2007, Current drug metabolism.
[53] Maria Almira Correia,et al. Cytochrome P450 regulation: the interplay between its heme* and apoprotein moieties in synthesis, assembly, repair, and disposal , 2011, Drug metabolism reviews.
[54] Ernesto Callegari,et al. A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.
[55] William M. Lee,et al. Pharmacokinetics of Acetaminophen-Protein Adducts in Adults with Acetaminophen Overdose and Acute Liver Failure , 2009, Drug Metabolism and Disposition.
[56] Paavo Honkakoski,et al. Inhibition and induction of human cytochrome P450 enzymes: current status , 2008, Archives of Toxicology.
[57] R Scott Obach,et al. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. , 2009, Chemical research in toxicology.
[58] Michael P Holt,et al. Drug-induced liver injury. , 2010, Handbook of experimental pharmacology.
[59] Yan Li,et al. Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development. , 2011, Chemico-biological interactions.
[60] William M. Lee,et al. Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study , 2010, Hepatology.
[61] P. van Bladeren. Glutathione conjugation as a bioactivation reaction. , 2000, Chemico-biological interactions.
[62] D. Adams,et al. Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.
[63] M. Christmann,et al. Mechanisms of human DNA repair: an update. , 2003, Toxicology.
[64] J. Boyer,et al. Bile salt transporters: molecular characterization, function, and regulation. , 2003, Physiological reviews.
[65] A Kosters,et al. Bile acid transporters in health and disease. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[66] Hongqiao Zhang,et al. Glutathione: overview of its protective roles, measurement, and biosynthesis. , 2009, Molecular aspects of medicine.
[67] J. Groopman,et al. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[68] D. G. McCarver,et al. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. , 2002, The Journal of pharmacology and experimental therapeutics.
[69] B Coles,et al. Effects of modifying structure on electrophilic reactions with biological nucleophiles. , 1984, Drug metabolism reviews.
[70] Shelly C. Lu. Regulation of glutathione synthesis. , 2009, Molecular aspects of medicine.
[71] G. Szabo,et al. Alcohol-induced Modulation of Signaling Pathways in Liver Parenchymal and Nonparenchymal Cells: Implications for Immunity , 2009, Seminars in liver disease.
[72] B. Friguet,et al. Proteasome function in aging and oxidative stress: implications in protein maintenance failure. , 2006, Antioxidants & redox signaling.
[73] N. Kitteringham,et al. The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. , 2010, Handbook of experimental pharmacology.
[74] K. Davies. Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems , 2000, IUBMB life.
[75] E. Kalinina,et al. Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes , 2008, Biochemistry (Moscow).
[76] B. Freeman,et al. Transduction of Redox Signaling by Electrophile-Protein Reactions , 2009, Science Signaling.
[77] S. Arnesen,et al. Environmental Health and Toxicology Resources of the United States National Library of Medicine , 2007, Medical reference services quarterly.
[78] Yan Liu,et al. The effects of splicing variant of PXR PAR-2 on CYP3A4 and MDR1 mRNA expressions. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[79] D. Halegoua-DeMarzio,et al. Drug-induced hepatotoxicity in humans. , 2008 .
[80] N. Kaplowitz,et al. Clinical Perspectives on Xenobiotic‐Induced Hepatotoxicity , 2004, Drug metabolism reviews.
[81] G. Kass. Mitochondrial involvement in drug-induced hepatic injury. , 2006, Chemico-biological interactions.
[82] J. Misdraji. Embryology, Anatomy, Histology, and Developmental Anomalies of the Liver , 2010 .
[83] William M. Lee,et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. , 2006, Gastroenterology.
[84] R. Hines,et al. Ontogeny of human hepatic cytochromes P450 , 2007, Journal of biochemical and molecular toxicology.
[85] J. Aikens,et al. Mechanisms and biological relevance of lipid peroxidation initiation. , 1993, Chemical research in toxicology.
[86] Rafael Radi,et al. Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. , 2009, ACS chemical biology.
[87] Irfan Rahman,et al. Redox modifications of protein-thiols: emerging roles in cell signaling. , 2006, Biochemical pharmacology.
[88] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[89] Magnus Ingelman-Sundberg,et al. The human genome project and novel aspects of cytochrome P450 research. , 2005, Toxicology and applied pharmacology.
[90] Antonio Colombi,et al. Toward an "omic" physiopathology of reactive chemicals: thirty years of mass spectrometric study of the protein adducts with endogenous and xenobiotic compounds. , 2009, Mass spectrometry reviews.
[91] B. Zhivotovsky,et al. Cell death mechanisms and their implications in toxicology. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[92] M. Boroujerdi,et al. Biotransformation of Xenobiotics , 2015 .
[93] M. Schwab,et al. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation , 2008, Analytical and bioanalytical chemistry.
[94] W. Smith. Mechanism of Toxicity. , 1970 .
[95] M. Czaja,et al. Cell signaling in oxidative stress-induced liver injury. , 2007, Seminars in liver disease.
[96] R. Mason,et al. Free radicals in pharmacology and toxicology--selected topics. , 1981, Pharmacological reviews.
[97] D. Keppler,et al. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs , 2008, Expert opinion on drug metabolism & toxicology.
[98] P. Klatt,et al. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. , 2000, European journal of biochemistry.
[99] J. Hakkola,et al. Developmental expression of cytochrome P450 enzymes in human liver. , 1998, Pharmacology & toxicology.
[100] R. Pozos,et al. Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships. , 2005, Current medicinal chemistry.
[101] A. Daly. Drug-induced liver injury: past, present and future. , 2010, Pharmacogenomics.
[102] Curtis D. Klaassen,et al. Casarett and Doull's Toxicology. The Basic Science of Poisons , 1981 .
[103] J. Turrens. Superoxide Production by the Mitochondrial Respiratory Chain , 1997, Bioscience reports.
[104] Kim L R Brouwer,et al. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[105] Bernard Testa,et al. The Biochemistry of Drug Metabolism — An Introduction. Part 4. Reactions of Conjugation and Their Enzymes , 2009 .
[106] D. Schuppan,et al. Herbal hepatotoxicity. , 2005, Journal of hepatology.
[107] Dean P. Jones. Redefining oxidative stress. , 2006, Antioxidants & redox signaling.
[108] N. Kaplowitz. Biochemical and Cellular Mechanisms of Toxic Liver Injury , 2002, Seminars in liver disease.
[109] H. Naegeli,et al. Role of DNA repair in the protection against genotoxic stress. , 2009, EXS.
[110] Freya Q. Schafer,et al. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.
[111] W. Pryor. Free Radicals in Biology , 1976 .
[112] J. Uetrecht. Idiosyncratic drug reactions: past, present, and future. , 2008, Chemical research in toxicology.
[113] J. Iredale,et al. Liver fibrosis: cellular mechanisms of progression and resolution. , 2007, Clinical science.
[114] Peter Neuhaus,et al. Sex is a major determinant of CYP3A4 expression in human liver , 2003, Hepatology.
[115] S. Elledge,et al. The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.
[116] G. Poli,et al. 4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases. , 2008, Molecular aspects of medicine.
[117] Wei Duan,et al. Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance , 2005, Drug metabolism reviews.
[118] Michael P. Murphy,et al. How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.
[119] M. Cronin,et al. Metals, toxicity and oxidative stress. , 2005, Current medicinal chemistry.
[120] J. Uetrecht,et al. Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. , 2002, Current drug metabolism.
[121] N. Vermeulen,et al. Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine. , 2010, Chemical research in toxicology.
[122] Tak Yee Aw,et al. Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.
[123] N. Kaplowitz. Mechanisms of liver cell injury. , 2000, Journal of hepatology.
[124] P. Burcham. Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. , 1998, Mutagenesis.
[125] Wen Xie,et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. , 2006, The Journal of biological chemistry.
[126] M. Trauner,et al. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. , 2007, Biochimica et biophysica acta.
[127] T. Lynch,et al. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. , 2007, American family physician.
[128] Michael P Holt,et al. Mechanisms of drug-induced liver injury , 2006, The AAPS Journal.
[129] Wei Li,et al. Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. , 2010, Antioxidants & redox signaling.
[130] Steven D. Cohen,et al. Selective protein covalent binding and target organ toxicity. , 1997, Toxicology and applied pharmacology.
[131] Yoshiro Saito,et al. Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[132] D. Petersen,et al. Formation of liver microsomal MDA-protein adducts in mice with chronic dietary iron overload. , 1998, Toxicology letters.
[133] D. Nelson. The Cytochrome P450 Homepage , 2009, Human Genomics.
[134] M. Pirmohamed,et al. Are chemically reactive metabolites responsible for adverse reactions to drugs? , 2002, Current drug metabolism.
[135] L. Laine,et al. A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience , 2006, Pharmacoepidemiology and drug safety.
[136] J. Uetrecht,et al. The danger hypothesis applied to idiosyncratic drug reactions. , 2003, Handbook of experimental pharmacology.
[137] F. Liu,et al. Involvement of the immune system in idiosyncratic drug reactions. , 2011, Drug metabolism and pharmacokinetics.
[138] R. Mason,et al. CHAPTER 6 – Free-Radical Intermediates in the Metabolism of Toxic Chemicals , 1982 .
[139] Dominic P. Williams,et al. Toxicophores: groups and metabolic routes associated with increased safety risk. , 2002, Current opinion in drug discovery & development.
[140] B. Testa,et al. The Biochemistry of Drug Metabolism – An Introduction , 2007, Chemistry & biodiversity.
[141] W. Alrefai,et al. Bile Acid Transporters: Structure, Function, Regulation and Pathophysiological Implications , 2007, Pharmaceutical Research.
[142] Defeng Wu,et al. Oxidative Stress and Alcoholic Liver Disease , 2009, Seminars in liver disease.
[143] A. Kosters,et al. The Role of Inflammation in Cholestasis: Clinical and Basic Aspects , 2010, Seminars in liver disease.
[144] C. Hershey,et al. Use of complementary and alternative medicines by ambulatory patients. , 2004, Archives of internal medicine.
[145] R. Benigni. Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches. , 2005, Chemical reviews.
[146] D. Keppler,et al. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. , 2008, Expert opinion on drug metabolism & toxicology.
[147] M. Gallogly,et al. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. , 2007, Current opinion in pharmacology.
[148] Sukyeong Lee,et al. Molecular chaperones in protein quality control. , 2005, Journal of biochemistry and molecular biology.
[149] Bernard Testa,et al. The Biochemistry of Drug Metabolism — An Introduction. Part 3. Reactions of Hydrolysis and Their Enzymes , 2007 .
[150] V. Navarro,et al. Drug-induced hepatotoxicity in humans. , 2008, Current opinion in drug discovery & development.
[151] Y. Awasthi,et al. Human glutathione S-transferases. , 1994, The International journal of biochemistry.
[152] W. Xie,et al. Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. , 2004, Drug discovery today.
[153] M. Czaja,et al. Hepatocytes Sensitized to Tumor Necrosis Factor-α Cytotoxicity Undergo Apoptosis through Caspase-dependent and Caspase-independent Pathways* , 2000, The Journal of Biological Chemistry.
[154] A. Baird,et al. Microanatomy of the liver immune system , 2009, Seminars in Immunopathology.
[155] L. James,et al. Mechanisms of acetaminophen-induced liver necrosis. , 2010, Handbook of experimental pharmacology.
[156] B. Testa,et al. The Biochemistry of Drug Metabolism — An Introduction. Part 5. Metabolism and Bioactivity , 2009 .
[157] N. Breusing,et al. Regulation of proteasome-mediated protein degradation during oxidative stress and aging , 2008, Biological chemistry.
[158] W. S. Baldwin,et al. Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation. , 2009, Current pharmacogenomics and personalized medicine.
[159] P. Meier,et al. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. , 2010, Seminars in liver disease.
[160] J. Uetrecht,et al. New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. , 1999, Chemical research in toxicology.
[161] B. Friguet,et al. Oxidized mitochondrial protein degradation and repair in aging and oxidative stress. , 2010, Antioxidants & redox signaling.
[162] H. Dienes,et al. Pathology of Immune-Mediated Liver Injury , 2010, Digestive Diseases.
[163] D. Green,et al. Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.
[164] D. Pessayre,et al. Mitochondrial involvement in drug-induced liver injury. , 2010, Handbook of experimental pharmacology.
[165] Daniel C Liebler,et al. Protein damage by reactive electrophiles: targets and consequences. , 2008, Chemical research in toxicology.
[166] J. Gutteridge,et al. Biological origin of free radicals, and mechanisms of antioxidant protection. , 1994, Chemico-biological interactions.
[167] S. Korsmeyer,et al. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.
[168] N. Kaplowitz,et al. Glutathione in liver diseases and hepatotoxicity. , 2009, Molecular aspects of medicine.
[169] R. Maronpot,et al. New Insights into Functional Aspects of Liver Morphology , 2005, Toxicologic pathology.
[170] M. Trauner,et al. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. , 2006, Molecular pharmaceutics.
[171] S. Mueller,et al. Compartment-dependent management of H(2)O(2) by peroxisomes. , 2007, Free radical biology & medicine.
[172] T. Baillie,et al. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.